Literature DB >> 28399457

Cumulative pain-related stress and developmental outcomes among low-risk preterm infants at one year corrected age.

Iris Morag1, Ifat Rotem2, Mor Frisch3, Israel Hendler4, Michal J Simchen5, Leah Leibovitz6, Ayala Maayan-Metzger7, Tzipora Strauss6.   

Abstract

BACKGROUND: Extensive exposure of preterm infants to pain-related stress (PRS) at a time of physiological immaturity and rapid brain development may contribute to altered neurodevelopment.
OBJECTIVE: To examine the relationship between early PRS and neurodevelopmental outcomes among low-risk very preterm infants at the age of one year corrected age (CA).
METHODS: Participants included 107 infants born <32weeks gestational age (GA) and monitored prospectively at 12.5months CA. Excluded were infants with severe neonatal morbidities associated with impaired neurodevelopment. PRS documentation was performed via the number of skin-breaking procedures (SBP) and by the use of the neonatal infant stressor scale (NISS). Adjustment was made for early neonatal morbidities.
RESULTS: Developmental outcomes among the study infants were within the norm (mean 100±11.03). Infants who underwent invasive mechanical ventilation (IMV) (n=31) were exposed to significantly more PRS than non-IMV infants (n=76) (p<0.000). Developmental outcomes were similar in both groups (99.7±11.1 vs. 100.8±11 p=0.63). Among IMV infants, increased exposure to PRS was associated with lower developmental scores independent of GA, gender or other sociodemographic factors.
CONCLUSION: Increased exposure to PRS among low-risk preterm infants who underwent IMV is associated with lower developmental scores at 12.5month CA.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28399457     DOI: 10.1016/j.earlhumdev.2017.03.010

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  2 in total

1.  Measures of Stress Exposure for Hospitalized Preterm Infants.

Authors:  Marliese Dion Nist; Tondi M Harrison; Rita H Pickler; Abigail B Shoben
Journal:  Nurs Res       Date:  2020 Sep/Oct       Impact factor: 2.381

Review 2.  Magnesium sulfate and fetal neuroprotection: overview of clinical evidence.

Authors:  Clément Chollat; Stéphane Marret
Journal:  Neural Regen Res       Date:  2018-12       Impact factor: 5.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.